AI assistant
Sending…
EyePoint Pharmaceuticals, Inc. — Director's Dealing 2011
Dec 1, 2011
32254_dirs_2011-12-01_a5325bb6-33a8-4f9c-87c3-eab83414e080.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: pSivida Corp. (PSDV)
CIK: 0001314102
Period of Report: 2011-11-29
Reporting Person: Ashton Paul (Director, President and CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-11-29 | Employee Stock Option (right to buy) | $5.05 | A | 135000 | Acquired | 2021-07-21 | Common Stock (135000) | Direct |
Footnotes
F1: The option becomes exercisable in four equal annual installments beginning on July 21, 2012.
More from EyePoint Pharmaceuticals, Inc.
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 13
Director's Dealing
2026
Mar 24
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 4
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 18
Major Shareholding Notification
2026
Feb 12
Director's Dealing
2026
Jan 7